About ChromaDex
ChromaDex is a company based in Irvine (United States) founded in 1999. ChromaDex has raised $3.39 million across 23 funding rounds from investors including dsm-firmenich, Hercules Capital and Western Alliance Bank. The company has 228 employees as of December 31, 2022. ChromaDex offers products and services including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards. ChromaDex operates in a competitive market with competitors including Kapiva, Labomar, Setu, BBetter and LifeVantage, among others.
- Headquarter Irvine, United States
- Employees 228 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Niagen Bioscience
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.39 M (USD)
in 23 rounds
-
Latest Funding Round
$16.39 M (USD), Post-IPO
Feb 22, 2021
-
Investors
dsm-firmenich
& 4 more
-
Employee Count
228
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ChromaDex
ChromaDex offers a comprehensive portfolio of products and services, including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards.
NAD-boosting supplement for enhancing cellular health and longevity.
Advanced therapy for fast-acting NAD+ enhancement in health enthusiasts.
Proprietary components for dietary supplements and pharmaceutical use.
Standards for scientific studies in NAD+ and related fields.
People of ChromaDex
Unlock access to complete
Unlock access to complete
Funding Insights of ChromaDex
ChromaDex has successfully raised a total of $3.39M across 23 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.39 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ChromaDex
ChromaDex has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include dsm-firmenich, Hercules Capital and Western Alliance Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Locked | Locked | Locked | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked | |
|
Commercial banking services, including loans and treasury management, are provided.
|
Locked | Locked | Locked |
Investor details for ChromaDex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ChromaDex
Investment portfolio details for ChromaDex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ChromaDex
Detailed financials for ChromaDex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chromadex Comparisons
Peer comparison for ChromaDex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ChromaDex
ChromaDex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, Labomar, Setu, BBetter and LifeVantage, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| Locked | Locked | Locked |
Dietary supplements, diet foods, health products, and medical devices
|
|
| Locked | Locked | Locked |
Dietary supplements with herbal extracts and vitamins are provided.
|
|
| Locked | Locked | Locked |
Nutritional supplements are provided to enhance health and wellness.
|
|
| Locked | Locked | Locked |
Nutritional products for various health ailments are provided.
|
Detailed competitors of ChromaDex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chromadex
Complete news archive for ChromaDex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChromaDex
ChromaDex was founded in 1999 and raised its 1st funding round 8 years after it was founded.
ChromaDex is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
ChromaDex is a funded company, having raised a total of $3.39M across 23 funding rounds to date.
As of Dec 31, 2022, the latest employee count at ChromaDex is 228.
ChromaDex was founded in 1999 in Irvine, United States, within the health and wellness sector. Nutritional ingredients are developed by the company, with operations centered on research into nicotinamide adenine dinucleotide (NAD), levels of which decline with age. Niagen is provided as the sole active ingredient in the consumer product Tru Niagen, supporting broader efforts in nutritional innovation.
ChromaDex's top competitors include Kapiva, Setu and LifeVantage.
ChromaDex offers Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards.
ChromaDex has 5 investors. Key investors include dsm-firmenich, Hercules Capital, Western Alliance Bank, Horizons Ventures, and National Science Foundation.